세계의 건선성 관절염 치료 시장 보고서(2024년)

Psoriatic Arthritis Treatment Global Market Report 2024

US $ 5,000 ￦ 7,234,000

PDF (Single User License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 7,500 ￦ 10,851,000

PDF (Site License)

PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 10,000 ￦ 14,469,000

PDF (Enterprise License)

PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

한글목차

건선성 관절염 치료제 시장 규모는 향후 몇 년 동안 크게 성장할 것으로 예상됩니다. 2028년에는 9.4%의 연평균 복합 성장률(CAGR)로 171억 6,000만 달러 규모로 성장할 것으로 예상됩니다. 이러한 성장에는 개인 맞춤형 의료의 발전, 새로운 생물학적 제제 및 저분자 치료제의 등장, 사용 가능한 치료 옵션의 확대, 전 세계 고령화 인구의 의료 수요 증가 등 몇 가지 중요한 요인이 영향을 미칠 것으로 예상됩니다.

건선과 건선성 관절염의 유병률 증가는 건선성 관절염 치료제 시장의 성장을 크게 견인하고 있습니다. 이러한 염증성 질환은 특히 동시에 발생하는 경우 개인의 건강과 삶의 질에 큰 영향을 미칩니다. 건선은 일반적으로 건선성 관절염과 관련이 있으며 전 세계적으로 상당한 비율의 사람들이 영향을받습니다. 예를 들어, 2021년 6월 미국 국립건선재단은 미국에서 8백만 명 이상, 전 세계적으로 1억 2,500만 명 이상이 건선으로 고통받고 있다고 보고했습니다. 또한 미국 건선 환자의 약 30%가 건선성 관절염을 앓고 있는 것으로 나타났습니다. 이러한 유병률의 증가는 시장 확대에 직접적으로 기여했습니다.

의료비 지출이 급증하면서 건선성 관절염 치료제 시장의 성장을 촉진했습니다. 의료비 지출 증가는 진료 예약, 임상 검사, 건선성 관절염 등 진단을 확정하는 데 필수적인 영상 검사 등 다양한 진단 절차에 도움이 됩니다. 예를 들어, 영국의 경우 2022년 의료비 지출은 약 3,477억 4,000만 달러로 전년 대비 0.7%의 명목상 증가율을 보였습니다. 이러한 의료 자원에 대한 투자 증가는 건선성 관절염과 같은 치료법의 성장에 기여하고 있습니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향과 전략

제4장 거시경제 시나리오

• 고인플레이션이 시장에 미치는 영향
• 우크라이나·러시아 전쟁이 시장에 미치는 영향
• COVID-19에 의한 시장에 대한 영향

제5장 세계 시장 규모와 성장

• 세계의 시장 성장 촉진요인과 억제요인
  • 시장 성장 촉진요인
  • 시장 성장 억제요인
• 세계의 시장 규모 실적과 성장, 2018-2023년
• 세계의 시장 규모 예측과 성장, 2023-2028년, 2033년

제6장 시장 세분화

• 세계의 건선성 관절염 치료 시장, 약제 클래스별 세분화, 실적 및 예측, 2018-2023년, 2023-2028년, 2033년
• 비스테로이드성 항염증제(NSAIDS)
• 질병 완화 항류마티스제(DMARDS)
• 생물학적 제제
• 기타 약제 클래스
• 세계의 건선성 관절염 치료 시장, 투여 경로별 세분화, 실적 및 예측, 2018-2023년, 2023-2028년, 2033년
• 비경구
• 외용
• 세계의 건선성 관절염 치료 시장, 유통 채널별 세분화, 실적 및 예측, 2018-2023년, 2023-2028년, 2033년
• 병원 약국
• 소매 약국
• 온라인 약국

제7장 지역 및 국가 분석

• 세계의 건선성 관절염 치료 시장, 지역별, 실적 및 예측, 2018-2023년, 2023-2028년, 2033년
• 세계의 건선성 관절염 치료 시장, 국가별, 실적 및 예측, 2018-2023년, 2023-2028년, 2033년

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 상황과 기업 개요

• 건선성 관절염 치료 시장 경쟁 상황
• 건선성 관절염 치료 시장 기업 개요
  • AbbVie Inc.
  • Amgen Astellas BioPharma KK
  • Johnson &Johnson Services Inc.
  • Bristol-Myers Squibb Company
  • Celgene Corporation

제31장 경쟁 벤치마킹

제32장 경쟁 대시보드

제33장 주요 인수합병

제34장 향후 전망과 가능성 분석

제35장 부록

ksm

영문 목차

영문목차

Psoriatic arthritis treatment aims to mitigate or halt the progression of a chronic inflammatory condition affecting joints and the areas where tendons and ligaments attach to bones (entheses). This treatment regimen concentrates on managing skin involvement, alleviating joint pain, and addressing associated disability.

The primary classes of drugs used in psoriatic arthritis treatment encompass nonsteroidal anti-inflammatory drugs (NSAIDs), disease-modifying anti-rheumatic drugs (DMARDs), biologics, and other medications. Biologic medicines, a subset of treatment options, are substances derived from or containing components of living organisms. These medications can be administered through various routes, including oral, parenteral (injection or infusion), and topical applications. They are distributed through diverse channels such as hospital pharmacies, retail pharmacies, and online pharmacies to cater to the needs of patients undergoing psoriatic arthritis treatment.

The psoriatic arthritis treatment market research report is one of a series of new reports from The Business Research Company that provides psoriatic arthritis treatment market statistics, including global market size, regional shares, competitors with a psoriatic arthritis treatment market share, detailed psoriatic arthritis treatment market segments, market trends and opportunities, and any further data you may need to thrive in the psoriatic arthritis treatment industry. This psoriatic arthritis treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The psoriatic arthritis treatment market size has grown strongly in recent years. It will grow from $10.93 billion in 2023 to $12 billion in 2024 at a compound annual growth rate (CAGR) of 9.8%. Historical growth in psoriatic arthritis treatment can be attributed to several factors. These include an uptick in diagnoses, a growing prevalence of psoriatic arthritis, increased awareness of the condition and its available treatments, a wider range of approved treatments for psoriatic arthritis, government support for research and development initiatives, and augmented investments from pharmaceutical companies. These combined elements contributed to the growth observed in the past period within the realm of psoriatic arthritis treatments.

The psoriatic arthritis treatment market size is expected to see strongly grown in the next few years. It will grow to $17.16 billion in 2028 at a compound annual growth rate (CAGR) of 9.4%. Anticipated growth in the upcoming period is linked to several key factors, including the advancement of personalized medicine, the emergence of new biologics and small molecule treatments, an expansion in the range of available treatment options, and the increasing global aging population's healthcare needs.

The increased prevalence of both psoriasis and psoriatic arthritis has significantly driven the growth of the psoriatic arthritis treatment market. These inflammatory disorders, particularly when occurring together, have a considerable impact on individuals' health and quality of life. Psoriasis, commonly associated with psoriatic arthritis, affects a significant percentage of individuals globally. For instance, in June 2021, the National Psoriasis Foundation reported that over 8 million people in the United States and 125 million worldwide suffered from psoriasis. Furthermore, approximately 30% of individuals with psoriasis in the USA also develop psoriatic arthritis. This rise in prevalence has directly contributed to market expansion.

The surge in healthcare spending has propelled the growth of the psoriatic arthritis treatment market. Increased healthcare expenditure supports various diagnostic procedures, including medical appointments, laboratory tests, and imaging studies essential for confirming diagnoses like psoriatic arthritis. For instance, in the UK, healthcare spending reached around $347.74 billion in 2022, demonstrating a 0.7% nominal increase from the previous year. This increased investment in healthcare resources contributes to the growth of treatments for conditions like psoriatic arthritis.

The development of novel drugs like Janus kinase (JAK) inhibitors has significantly shaped the market. JAK inhibitors, such as tofacitinib, baricitinib, and upadacitinib, have emerged as innovative treatments for psoriatic arthritis. These medications have gained approval from regulatory bodies like the FDA and EMA, offering effective options for patients who have had inadequate responses to other treatments.

Major pharmaceutical companies have also been instrumental in market growth by introducing new drugs like Cosentyx. This drug, developed by Novartis, is an interleukin-17A antagonist used to treat various autoimmune diseases, including psoriatic arthritis. In October 2023, its approval by the FDA marked a significant milestone, offering relief for symptoms like joint pain and skin problems associated with psoriatic arthritis.

In February 2023, Takeda Pharmaceutical Company, a Japan-based pharmaceutical company acquired Nimbus Therapeutics for an undisclosed amount. The acquisition is anticipated to improve Takeda Pharmaceutical's position in the market for psoriatic arthritis treatments and broaden its product line. Nimbus Therapeutics is a US-based biotechnology company. It develops drugs for psoriatic arthritis treatment.

Major companies operating in the psoriatic arthritis treatment market include AbbVie Inc., Amgen Astellas BioPharma K.K., Johnson & Johnson Services Inc., Bristol-Myers Squibb Company, Celgene Corporation, Novartis International AG, Eli Lilly and Company, Pfizer Inc., CB Biosciences Inc., Hoffmann-La Roche Ltd., Merck & Co. Inc., AstraZeneca PLC, Sanofi SA, Otsuka Pharmaceutical Co. Ltd., Sumitomo Dainippon Pharma Co. Ltd., Bayer AG, Abbott Laboratories, Eisai Inc., Janssen Pharmaceuticals Inc., Bausch Health Companies Inc., F. Hoffmann-La Roche Ltd., Gilead Sciences Inc., GlaxoSmithKline PLC, LEO Pharma A/S, Regeneron Pharmaceuticals Inc., Sun Pharmaceutical Industries Ltd., Takeda Pharmaceutical Company Limited, Teva Pharmaceutical Industries Ltd., Valeant Pharmaceuticals International Inc., Chugai Pharmaceutical Co. Ltd., Kyowa Kirin Co. Ltd.

North America was the largest region in the psoriatic arthritis treatment market in 2023. The regions covered in the psoriatic arthritis treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.

The countries covered in the psoriatic arthritis treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada.

The psoriatic arthritis treatment market includes revenues earned by entities by reducing pain and swelling and controlling inflammation and pain. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Psoriatic Arthritis Treatment Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on psoriatic arthritis treatment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
• Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
• Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
• Measure the impact of high global inflation on market growth.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for psoriatic arthritis treatment? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The psoriatic arthritis treatment market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

Scope

Markets Covered:

• 1) By Drug Class: Nonsteroidal Anti-Inflammatory Drugs (NSAIDS); Disease-Modifying Anti-Rheumatic Drugs (DMARDS); Biologics; Other Drug Classes
• 2) By Route Of Administration: Oral; Parenteral; Topical
• 3) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies
• Companies Mentioned: AbbVie Inc.; Amgen Astellas BioPharma K.K.; Johnson & Johnson Services Inc.; Bristol-Myers Squibb Company; Celgene Corporation
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Psoriatic Arthritis Treatment Market Characteristics

3. Psoriatic Arthritis Treatment Market Trends And Strategies

4. Psoriatic Arthritis Treatment Market - Macro Economic Scenario

• 4.1. Impact Of High Inflation On the Market
• 4.2. Ukraine-Russia War Impact On the Market
• 4.3. COVID-19 Impact On the Market

5. Global Psoriatic Arthritis Treatment Market Size and Growth

• 5.1. Global Psoriatic Arthritis Treatment Market Drivers and Restraints
  • 5.1.1. Drivers Of The Market
  • 5.1.2. Restraints Of The Market
• 5.2. Global Psoriatic Arthritis Treatment Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
• 5.3. Global Psoriatic Arthritis Treatment Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Psoriatic Arthritis Treatment Market Segmentation

• 6.1. Global Psoriatic Arthritis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Nonsteroidal Anti-Inflammatory Drugs (NSAIDS)
• Disease-Modifying Anti-Rheumatic Drugs (DMARDS)
• Biologics
• Other Drug Classes
• 6.2. Global Psoriatic Arthritis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Parenteral
• Topical
• 6.3. Global Psoriatic Arthritis Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies

7. Psoriatic Arthritis Treatment Market Regional And Country Analysis

• 7.1. Global Psoriatic Arthritis Treatment Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 7.2. Global Psoriatic Arthritis Treatment Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Psoriatic Arthritis Treatment Market

• 8.1. Asia-Pacific Psoriatic Arthritis Treatment Market Overview
• Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Psoriatic Arthritis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 8.3. Asia-Pacific Psoriatic Arthritis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 8.4. Asia-Pacific Psoriatic Arthritis Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Psoriatic Arthritis Treatment Market

• 9.1. China Psoriatic Arthritis Treatment Market Overview
• 9.2. China Psoriatic Arthritis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
• 9.3. China Psoriatic Arthritis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
• 9.4. China Psoriatic Arthritis Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Psoriatic Arthritis Treatment Market

• 10.1. India Psoriatic Arthritis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 10.2. India Psoriatic Arthritis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 10.3. India Psoriatic Arthritis Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Psoriatic Arthritis Treatment Market

• 11.1. Japan Psoriatic Arthritis Treatment Market Overview
• 11.2. Japan Psoriatic Arthritis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 11.3. Japan Psoriatic Arthritis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 11.4. Japan Psoriatic Arthritis Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Psoriatic Arthritis Treatment Market

• 12.1. Australia Psoriatic Arthritis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 12.2. Australia Psoriatic Arthritis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 12.3. Australia Psoriatic Arthritis Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Psoriatic Arthritis Treatment Market

• 13.1. Indonesia Psoriatic Arthritis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 13.2. Indonesia Psoriatic Arthritis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 13.3. Indonesia Psoriatic Arthritis Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Psoriatic Arthritis Treatment Market

• 14.1. South Korea Psoriatic Arthritis Treatment Market Overview
• 14.2. South Korea Psoriatic Arthritis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 14.3. South Korea Psoriatic Arthritis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 14.4. South Korea Psoriatic Arthritis Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Psoriatic Arthritis Treatment Market

• 15.1. Western Europe Psoriatic Arthritis Treatment Market Overview
• 15.2. Western Europe Psoriatic Arthritis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 15.3. Western Europe Psoriatic Arthritis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 15.4. Western Europe Psoriatic Arthritis Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Psoriatic Arthritis Treatment Market

• 16.1. UK Psoriatic Arthritis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 16.2. UK Psoriatic Arthritis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 16.3. UK Psoriatic Arthritis Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Psoriatic Arthritis Treatment Market

• 17.1. Germany Psoriatic Arthritis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 17.2. Germany Psoriatic Arthritis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 17.3. Germany Psoriatic Arthritis Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Psoriatic Arthritis Treatment Market

• 18.1. France Psoriatic Arthritis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 18.2. France Psoriatic Arthritis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 18.3. France Psoriatic Arthritis Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Psoriatic Arthritis Treatment Market

• 19.1. Italy Psoriatic Arthritis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 19.2. Italy Psoriatic Arthritis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 19.3. Italy Psoriatic Arthritis Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Psoriatic Arthritis Treatment Market

• 20.1. Spain Psoriatic Arthritis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 20.2. Spain Psoriatic Arthritis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 20.3. Spain Psoriatic Arthritis Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Psoriatic Arthritis Treatment Market

• 21.1. Eastern Europe Psoriatic Arthritis Treatment Market Overview
• 21.2. Eastern Europe Psoriatic Arthritis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 21.3. Eastern Europe Psoriatic Arthritis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 21.4. Eastern Europe Psoriatic Arthritis Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Psoriatic Arthritis Treatment Market

• 22.1. Russia Psoriatic Arthritis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 22.2. Russia Psoriatic Arthritis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 22.3. Russia Psoriatic Arthritis Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Psoriatic Arthritis Treatment Market

• 23.1. North America Psoriatic Arthritis Treatment Market Overview
• 23.2. North America Psoriatic Arthritis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 23.3. North America Psoriatic Arthritis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 23.4. North America Psoriatic Arthritis Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Psoriatic Arthritis Treatment Market

• 24.1. USA Psoriatic Arthritis Treatment Market Overview
• 24.2. USA Psoriatic Arthritis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 24.3. USA Psoriatic Arthritis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 24.4. USA Psoriatic Arthritis Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Psoriatic Arthritis Treatment Market

• 25.1. Canada Psoriatic Arthritis Treatment Market Overview
• 25.2. Canada Psoriatic Arthritis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 25.3. Canada Psoriatic Arthritis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 25.4. Canada Psoriatic Arthritis Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Psoriatic Arthritis Treatment Market

• 26.1. South America Psoriatic Arthritis Treatment Market Overview
• 26.2. South America Psoriatic Arthritis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 26.3. South America Psoriatic Arthritis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 26.4. South America Psoriatic Arthritis Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Psoriatic Arthritis Treatment Market

• 27.1. Brazil Psoriatic Arthritis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 27.2. Brazil Psoriatic Arthritis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 27.3. Brazil Psoriatic Arthritis Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Psoriatic Arthritis Treatment Market

• 28.1. Middle East Psoriatic Arthritis Treatment Market Overview
• 28.2. Middle East Psoriatic Arthritis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 28.3. Middle East Psoriatic Arthritis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 28.4. Middle East Psoriatic Arthritis Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Psoriatic Arthritis Treatment Market

• 29.1. Africa Psoriatic Arthritis Treatment Market Overview
• 29.2. Africa Psoriatic Arthritis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 29.3. Africa Psoriatic Arthritis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 29.4. Africa Psoriatic Arthritis Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Psoriatic Arthritis Treatment Market Competitive Landscape And Company Profiles

• 30.1. Psoriatic Arthritis Treatment Market Competitive Landscape
• 30.2. Psoriatic Arthritis Treatment Market Company Profiles
  • 30.2.1. AbbVie Inc.
    • 30.2.1.1. Overview
    • 30.2.1.2. Products and Services
    • 30.2.1.3. Strategy
    • 30.2.1.4. Financial Performance
  • 30.2.2. Amgen Astellas BioPharma K.K.
    • 30.2.2.1. Overview
    • 30.2.2.2. Products and Services
    • 30.2.2.3. Strategy
    • 30.2.2.4. Financial Performance
  • 30.2.3. Johnson & Johnson Services Inc.
    • 30.2.3.1. Overview
    • 30.2.3.2. Products and Services
    • 30.2.3.3. Strategy
    • 30.2.3.4. Financial Performance
  • 30.2.4. Bristol-Myers Squibb Company
    • 30.2.4.1. Overview
    • 30.2.4.2. Products and Services
    • 30.2.4.3. Strategy
    • 30.2.4.4. Financial Performance
  • 30.2.5. Celgene Corporation
    • 30.2.5.1. Overview
    • 30.2.5.2. Products and Services
    • 30.2.5.3. Strategy
    • 30.2.5.4. Financial Performance

31. Global Psoriatic Arthritis Treatment Market Competitive Benchmarking

32. Global Psoriatic Arthritis Treatment Market Competitive Dashboard

33. Key Mergers And Acquisitions In The Psoriatic Arthritis Treatment Market

34. Psoriatic Arthritis Treatment Market Future Outlook and Potential Analysis

• 34.1 Psoriatic Arthritis Treatment Market In 2028 - Countries Offering Most New Opportunities
• 34.2 Psoriatic Arthritis Treatment Market In 2028 - Segments Offering Most New Opportunities
• 34.3 Psoriatic Arthritis Treatment Market In 2028 - Growth Strategies
  • 34.3.1 Market Trend Based Strategies
  • 34.3.2 Competitor Strategies

35. Appendix

• 35.1. Abbreviations
• 35.2. Currencies
• 35.3. Historic And Forecast Inflation Rates
• 35.4. Research Inquiries
• 35.5. The Business Research Company
• 35.6. Copyright And Disclaimer

관련자료